BenevolentAI
target discovery tools and process promising novel therapeutic targets target target prediction can we treat als by reversing autophagy impairment in microglia by reducing oxidative stress the tech approach triage and assess targets validate experimentally identifies | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
34 of 74
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Presentation
October 2022
target discovery tools and process promising novel therapeutic targets target prediction can we treat als by reversing autophagy impairment in microglia by reducing oxidative stress the tech approach triage and assess targets validate experimentally identifies | BenevolentAI
Related slides by other companies
DICE Therapeutics
Investor Presentation
March 2023
the dice approach | DICE Therapeutics
Absci
Investor Presentation
October 2023
integrated drug creation platform process | Absci
Absci
Investor Presentation
October 2023
harnessing the human adaptive immune response to identify novel targets and therapeutics | Absci
Moelis & Company
Investment Banking
April 2016
our approach to working with the special committee would work with the special committee and to design the right process as we evaluate key issues including is this the right time and is this the right target | Moelis & Company
Other recent decks by BenevolentAI
See all presentations (11 decks)
Investor Presentation
September 2024
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights